title: Recurrence of abdominal large-vessel vasculitis and development of severe Sweet syndrome after a single cycle of 5-azacytidine in a patient with myelodysplastic syndrome.
authors.affiliation: Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.
authors.forename: Hiroki
authors.initials: H
authors.lastname: Kawano
authors.forename: Tomohide
authors.initials: T
authors.lastname: Suzuki
authors.forename: Shinichi
authors.initials: S
authors.lastname: Ishii
authors.forename: Kanako
authors.initials: K
authors.lastname: Wakahashi
authors.forename: Yuko
authors.initials: Y
authors.lastname: Kawano
authors.forename: Akiko
authors.initials: A
authors.lastname: Sada
authors.forename: Kentaro
authors.initials: K
authors.lastname: Minagawa
authors.forename: Daisuke
authors.initials: D
authors.lastname: Ueno
authors.forename: Takashi
authors.initials: T
authors.lastname: Yamasaki
authors.forename: Tomoo
authors.initials: T
authors.lastname: Itoh
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Yokozaki
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Katayama
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D001374:Azacitidine / Q000009:adverse effects* / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000188:drug therapy; D016463:Sweet Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D014657:Vasculitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine